Kura Oncology Inc. (KURA) at a glance

Kura Oncology Inc. (KURA) is a small-cap Healthcare company. It trades at $12.7, with a 99.9% profit margin and revenue growth of 29.5%. It does not pay a dividend. Vestovix scores it 66/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$12.70

Market cap

$803.4M

P/E ratio

n/a

Dividend yield

None

Beta

0.36

52-week range

$7.36 to $13.90